These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31256476)

  • 1. An ageing methadone population: A challenge for treating doctors.
    Nagarajan S; Wong A; Greene SL; Koutsogiannis Z
    Aust J Gen Pract; 2019 Mar; 48(3):111-112. PubMed ID: 31256476
    [No Abstract]   [Full Text] [Related]  

  • 2. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al.
    McCarthy JJ
    J Addict Med; 2016; 10(2):133-4. PubMed ID: 26985649
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
    Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
    Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study.
    Dennis BB; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; Thabane L; Samaan Z; Ahmed A
    Drug Alcohol Depend; 2020 Apr; 209():107917. PubMed ID: 32088589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid substitution: improving cost-efficiency.
    Sullivan S
    Bull World Health Organ; 2013 Feb; 91(2):83. PubMed ID: 23554517
    [No Abstract]   [Full Text] [Related]  

  • 8. Marked Symptomatic Sinus Bradycardia With New Onset First-Degree Atrioventricular Block After Concomitant Methadone and Trazodone Use.
    Saeed M; Tripathi D; Chaudhari S
    Am J Ther; 2018; 25(5):e575-e577. PubMed ID: 28953513
    [No Abstract]   [Full Text] [Related]  

  • 9. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
    Salsitz E; Wiegand T
    J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment.
    Stimmel B
    J Addict Dis; 2011 Oct; 30(4):307-8. PubMed ID: 22026520
    [No Abstract]   [Full Text] [Related]  

  • 13. A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
    Ling W
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):394-400. PubMed ID: 27008037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improve the benefit/risk balance of methadone by respecting its pharmacological specificities].
    Frauger E; Fouilhé Sam-Laï N; Mallaret M; Micallef J;
    Therapie; 2019 Jun; 74(3):383-388. PubMed ID: 31178032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
    Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
    J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence.
    Levy-Gigi E; Kéri S; Shapiro AR; Sason A; Adelson M; Peles E
    Drug Alcohol Depend; 2014 Nov; 144():111-8. PubMed ID: 25220895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to dealing with opioid drug dependence.
    Rushforth BJ; Wright NM
    Br J Gen Pract; 2011 Dec; 61(593):710-1. PubMed ID: 22137383
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication-assisted treatment of opiate dependence is gaining favor.
    Jerry JM; Collins GB
    Cleve Clin J Med; 2013 Jun; 80(6):345-9. PubMed ID: 23733899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?
    Bart G
    J Addict Dis; 2011 Oct; 30(4):313-7. PubMed ID: 22026522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.